Morana Jovan-Embiricos

Insider Reports History

Location
Boston, MA
Signature
/s/ Brett Hagen, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Morana Jovan-Embiricos:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cullinan Oncology, Inc. 10%+ Owner Common Stock 1,305,873 $16,271,178 $12.46 24 Jun 2022 By F2 Vision SCS
Cullinan Oncology, Inc. 10%+ Owner Common Stock 1,136,525 $14,161,102 $12.46 24 Jun 2022 By Globeways Holdings Ltd.
Allovir, Inc. Director Common Stock 16,674,766 $13,211,417 $0.7923 06 Jun 2024 Shares held by ElevateBio LLC
Cullinan Oncology, Inc. 10%+ Owner Common Stock 622,175 $7,752,301 $12.46 24 Jun 2022 By F2-TPO Investments, LLC
Cullinan Oncology, Inc. 10%+ Owner Common Stock 537,392 $6,695,904 $12.46 24 Jun 2022 By F2 Bioscience I 2017 Ltd.
Cullinan Oncology, Inc. 10%+ Owner Common Stock 325,333 $4,053,649 $12.46 24 Jun 2022 By F2 MG Ltd.
Allovir, Inc. Director Common Stock 4,193,874 $3,322,806 $0.7923 06 Jun 2024 F2 Capital I 2020 LLC
Cullinan Oncology, Inc. 10%+ Owner Common Stock 214,798 $2,676,383 $12.46 24 Jun 2022 By F2 MC, LLC
Cullinan Oncology, Inc. 10%+ Owner Common Stock 207,803 $2,589,225 $12.46 24 Jun 2022 Direct
Allovir, Inc. Director Common Stock 2,059,884 $1,632,046 $0.7923 06 Jun 2024 F2 MG Ltd.
Allovir, Inc. Director Common Stock 2,038,583 $1,615,169 $0.7923 06 Jun 2024 Shares held by F2 MC, LLC
Cullinan Oncology, Inc. 10%+ Owner Common Stock 104,762 $1,305,335 $12.46 24 Jun 2022 By F2 GC, LLC
Cullinan Oncology, Inc. 10%+ Owner Common Stock 71,599 $892,124 $12.46 24 Jun 2022 By F2 Bio TD, LLC
Allovir, Inc. Director Common Stock 867,678 $687,461 $0.7923 06 Jun 2024 F2 Bioscience AV 2022 LLC
Allovir, Inc. Director Common Stock 668,072 $529,313 $0.7923 06 Jun 2024 Shares held by F2 TPO Investments, LLC
Allovir, Inc. Director Common Stock 100,197 $79,386 $0.7923 06 Jun 2024 Direct
Kalaris Therapeutics, Inc. Director Stock Option (Right to Buy) 18,000 10 Apr 2025 Direct
Cullinan Oncology, Inc. 10%+ Owner Stock Option (Right to Buy) 0 24 Jun 2022 Direct

Insider Reports Filed by Morana Jovan-Embiricos

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KLRS Kalaris Therapeutics, Inc. 10 Apr 2025 1 $0 4 Director 11 Apr 2025, 17:08
KLRS Allovir, Inc. 06 Jun 2024 1 $0 4 Director, 10%+ Owner 07 Jun 2024, 16:05
KLRS Allovir, Inc. 11 May 2023 1 $0 4 Director, 10%+ Owner 12 May 2023, 17:00
KLRS Allovir, Inc. 28 Jul 2022 6 +$37,581,859 4 Director, 10%+ Owner 01 Aug 2022, 16:35
CGEM Cullinan Oncology, Inc. 24 Jun 2022 5 +$13.78 4 10%+ Owner 28 Jun 2022, 21:24
KLRS Allovir, Inc. 17 May 2022 1 $0 4 Director, 10%+ Owner 19 May 2022, 16:28
KLRS Allovir, Inc. 10 Nov 2021 2 -$19,812 4 Director 15 Nov 2021, 16:17
KLRS Allovir, Inc. 05 Nov 2021 4 -$302,455 4 Director 09 Nov 2021, 17:43
KLRS Allovir, Inc. 27 Oct 2021 2 -$54,510 4 Director 29 Oct 2021, 17:02
KLRS Allovir, Inc. 21 Oct 2021 6 -$337,045 4 Director 25 Oct 2021, 18:24
CGEM Cullinan Oncology, Inc. 16 Sep 2021 1 $0 4 Director 25 Mar 2022, 19:32
KLRS Allovir, Inc. 25 May 2021 1 $0 4 Director, 10%+ Owner 27 May 2021, 16:45